Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK

Girijesh Kumar Patel(University of South Alabama), Ajay P. Singh(USA Mitchell Cancer Institute)

British Journal of Cancer

February 1, 2017

10.1038/bjc.2017.18

Cited by 257

Related Papers

Comparative analysis of exosome isolation methods using culture supernatant for optimum yield, purity and downstream applications

|Scientific Reports|2019|633

CXCL12–CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy

|British Journal of Cancer|2010|221

An Undesired Effect of Chemotherapy

|Journal of Biological Chemistry|2013|164

Honokiol Arrests Cell Cycle, Induces Apoptosis, and Potentiates the Cytotoxic Effect of Gemcitabine in Human Pancreatic Cancer Cells

|PLoS ONE|2011|132

CXCL12/CXCR4 Protein Signaling Axis Induces Sonic Hedgehog Expression in Pancreatic Cancer Cells via Extracellular Regulated Kinase- and Akt Kinase-mediated Activation of Nuclear Factor κB

|Journal of Biological Chemistry|2012|121